深圳惠泰(tai)醫療(liao)器(qi)(qi)械(xie)股份有(you)限公司是一(yi)家專注于心臟電生理和(he)介(jie)入(ru)(ru)醫療(liao)器(qi)(qi)械(xie)的(de)研發、生產和(he)銷售的(de)高新技術(shu)企業,已形成了以完整冠脈(mo)通路和(he)心臟電生理醫療(liao)器(qi)(qi)械(xie)為主導,外(wai)周血管和(he)神經介(jie)入(ru)(ru)醫療(liao)器(qi)(qi)械(xie)為重(zhong)點發展方向(xiang)的(de)業務布局。于2021年(nian)1月7日在(zai)上(shang)海證(zheng)(zheng)券交易所科創板上(shang)市,證(zheng)(zheng)券簡稱“惠泰(tai)醫療(liao)”,證(zheng)(zheng)券代碼“688617”。
在電(dian)(dian)(dian)(dian)(dian)生(sheng)(sheng)理(li)(li)器(qi)械領域,公司是獲(huo)得(de)電(dian)(dian)(dian)(dian)(dian)生(sheng)(sheng)理(li)(li)電(dian)(dian)(dian)(dian)(dian)極(ji)導(dao)(dao)(dao)管、可控射(she)頻消(xiao)融電(dian)(dian)(dian)(dian)(dian)極(ji)導(dao)(dao)(dao)管、漂浮(fu)臨時(shi)起搏電(dian)(dian)(dian)(dian)(dian)極(ji)導(dao)(dao)(dao)管市(shi)場準入并(bing)進入臨床應(ying)用(yong)(yong)的(de)(de)國產廠家(jia),打破了國外產品在該領域的(de)(de)壟斷。公司電(dian)(dian)(dian)(dian)(dian)生(sheng)(sheng)理(li)(li)電(dian)(dian)(dian)(dian)(dian)極(ji)導(dao)(dao)(dao)管和可控射(she)頻消(xiao)融電(dian)(dian)(dian)(dian)(dian)極(ji)導(dao)(dao)(dao)管同時(shi)被(bei)科技部(bu)認定(ding)為國家(jia)重點新產品、被(bei)深圳(zhen)科工(gong)貿信委認定(ding)為深圳(zhen)市(shi)自主創新產品,可控射(she)頻消(xiao)融導(dao)(dao)(dao)管被(bei)廣東省科技廳認定(ding)為高(gao)(gao)新技術產品。公司三(san)維(wei)心臟電(dian)(dian)(dian)(dian)(dian)生(sheng)(sheng)理(li)(li)標測(ce)(ce)系(xi)統采用(yong)(yong)國際主流磁電(dian)(dian)(dian)(dian)(dian)融合定(ding)位原理(li)(li),創新性(xing)地將電(dian)(dian)(dian)(dian)(dian)生(sheng)(sheng)理(li)(li)手術中常(chang)用(yong)(yong)的(de)(de)三(san)維(wei)標測(ce)(ce)系(xi)統、多(duo)道記錄儀、刺激儀功能(neng)集于一(yi)身,極(ji)大地提高(gao)(gao)了手術效率,將心臟電(dian)(dian)(dian)(dian)(dian)生(sheng)(sheng)理(li)(li)標測(ce)(ce)系(xi)統的(de)(de)發展推(tui)向了一(yi)個新高(gao)(gao)度。
在(zai)血(xue)管介入器械領域,薄壁鞘(qiao)(qiao)(血(xue)管鞘(qiao)(qiao)組)為國(guo)產(chan)獨(du)家產(chan)品,微導(dao)管(冠脈應用)和可調(diao)閥導(dao)管鞘(qiao)(qiao)(導(dao)管鞘(qiao)(qiao)組)為國(guo)內(nei)首個(ge)獲得注冊(ce)證(zheng)的國(guo)產(chan)同(tong)類產(chan)品。錨(mao)定球囊擴張導(dao)管是(shi)國(guo)內(nei)首個(ge)導(dao)引導(dao)管內(nei)采用球囊錨(mao)定方式(shi)進行導(dao)管交換(huan)的創新醫療器械。導(dao)引導(dao)絲(si)為國(guo)產(chan)首個(ge)采用復合雙芯設計的導(dao)絲(si),并有(you)多種(zhong)型號(hao)適合各(ge)種(zhong)臨床需(xu)求(qiu)。
惠(hui)泰醫(yi)療(liao)(liao)高度(du)重視研發人才的(de)培養(yang),通(tong)過科(ke)學的(de)人才培養(yang)體系和(he)合理的(de)激勵機制,打造了一個(ge)(ge)高層次、高學歷、跨學科(ke),全(quan)面、穩定且競爭力強的(de)研發團隊。擁有(you)已(yi)(yi)授(shou)權(quan)的(de)境內(nei)外專利(li)109項,其中境內(nei)授(shou)權(quan)專利(li)107項,境外授(shou)權(quan)發明專利(li)2項。已(yi)(yi)取(qu)得51個(ge)(ge)國內(nei)醫(yi)療(liao)(liao)器(qi)械注冊及備案證(zheng)書(shu),其中Ⅲ類(lei)(lei)醫(yi)療(liao)(liao)器(qi)械注冊證(zheng)47個(ge)(ge)。在(zai)國內(nei)市(shi)場,公司心(xin)臟電(dian)生理產品覆蓋(gai)醫(yi)院(yuan)超過800家(jia),血管(guan)介入類(lei)(lei)產品覆蓋(gai)醫(yi)院(yuan)超過3000家(jia)。同時,公司已(yi)(yi)取(qu)得14個(ge)(ge)產品的(de)歐盟CE認證(zheng),在(zai)其他(ta)九十多個(ge)(ge)國家(jia)和(he)地區完成注冊和(he)市(shi)場準入。
惠泰醫(yi)療(liao)將始終(zhong)致力于自(zi)主(zhu)創新和在(zai)心腦血管微創介(jie)入領域的發展(zhan),并將為推動全(quan)球醫(yi)療(liao)事業(ye)發展(zhan)做出卓越的貢獻(xian)。